Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...
Patent
1975-10-01
1976-12-28
Curtis, Allen B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Fungus, except allergen, or component thereof or substance...
260240R, C07D20904, C07D20912
Patent
active
040003051
ABSTRACT:
This invention relates to novel 15-, 16- and 17-heterocyclyl nor-prostanoic acid derivatives, for example 9.alpha.,11.alpha.,15-trihydroxy-16-(indol-5-yloxy)-17,18,19,20-tetranor-5 -cis, 13-trans-prostadienoic acid, which have a unique profile of Prostaglandin-like properties, and to processes for their manufacture, and also to pharmaceutical or veterinary compositions containing one of said novel derivatives, and a method of inducing luteolysis in an animal host by administering one of said novel derivatives.
REFERENCES:
patent: 3821279 (1974-06-01), Kurono et al.
patent: 3872107 (1975-03-01), Crabbe
patent: 3903131 (1975-09-01), Magerlein
Bowler Jean
Mallion Keith Blakeney
Richardson Dora Nellie
Curtis Allen B.
Imperial Chemical Industries Limited
LandOfFree
15-, 16- AND 17-Indolyl or indolinyl nor prostanoic acid derivat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 15-, 16- AND 17-Indolyl or indolinyl nor prostanoic acid derivat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 15-, 16- AND 17-Indolyl or indolinyl nor prostanoic acid derivat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-149250